Return to Play After ACL Reconstruction With Bone Marrow Aspirate, DBM, and an Internal Brace

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age14-26
SponsorMarshall University

About this trial

The Investigators are studying the effect of an ACL reconstruction on return to play by capturing outcome measures and biomechanics information.

Eligibility criteria

Qualifiers

Patients must be age 14-26 years old.

Skeletally mature patients, with an ACL deficient knee who desire to have ACL reconstructive surgery using autograft augmentation.

Patients must be a tanner stage of 5 and a posteroanterior left hand film x-ray will be obtained to confirm bone age and skeletal maturity

Patients with associated meniscal and chondral pathology (except patients falling into

Disqualifiers

An understanding of the purpose of the study and providing written informed consent.

Patients with multi-ligament surgery (MCL, PCL, LCL, PMC, or PLC repair or reconstruction),

Patients who have undergone previous ACL reconstructive surgery.

Patients who are currently pregnant or nursing.

Trial design

Treatments tested in this trial

  • Fertilized ACL

Treatment groups

450 Participants
are divided into 2 treatment groups

Sponsors and collaborators

Marshall University

Lead sponsor

Arthrex, Inc.

Collaborator